Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash provided by (used for) operating activities
Net income (loss)	$ 584	$ 370
Depreciation and amortization	583	558
Deferred and prepaid income taxes	(45)	(93)
Stock-based compensation expense	115	107
Goodwill and other intangible asset impairment charges	57	7
Net loss (gain) on investments and notes receivable	35	36
Contingent consideration net expense (benefit)	31	48
Inventory step-up amortization	3	25
Gain (Loss) on Extinguishment of Debt	0	194
Other, net	23	31
Trade accounts receivable	(161)	(162)
Inventories	(399)	(180)
Other assets	(55)	(244)
Accounts payable, accrued expenses and other liabilities	78	(449)
Cash provided by (used for) operating activities	848	249
Investing activities:
Purchases of property, plant and equipment and internal use software	(254)	(226)
Proceeds from sale of property, plant and equipment	3	9
Payments for acquisitions of businesses, net of cash acquired	(1,018)	(1,471)
Proceeds from royalty rights	16	36
Payments for (Proceeds from) Hedge, Investing Activities	2	56
Proceeds from (payments for) investments and acquisitions of certain technologies	(73)	(10)
Cash provided by (used for) investing activities	(1,324)	(1,603)
Financing activities:
Payment of contingent consideration previously established in purchase accounting	(39)	(283)
Payments for royalty rights	(34)	(39)
Payments on short-term borrowings	0	(250)
Net increase (decrease) in commercial paper	37	154
Payments on long-term borrowings and debt extinguishment costs	0	(3,184)
Proceeds from long-term borrowings, net of debt issuance costs	0	3,270
Cash dividends paid on preferred stock	(28)	(28)
Cash used to net share settle employee equity awards	(52)	(47)
Proceeds from issuances of common stock pursuant to employee stock compensation and purchase plans	90	58
Cash provided by (used for) financing activities	(26)	(350)
Effect of foreign exchange rates on cash	(3)	(6)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	(506)	(1,710)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	1,126	2,168
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	$ 620	$ 458